跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KOSELUGO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
KOSELUGO
Authorized
STANDARD
KOSELUGO
Alexion Pharma GmbH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3e5b76a04fa3926e
Company
Alexion Pharma GmbH
Type
Standard
Approval Details
Approval Id
3e5b76a04fa3926e
Drug Approval Canada Name
KOSELUGO
Product Name
KOSELUGO
Status
Marketed
Status Date
2024-04-26
Original Market Date
2023-01-03
Din
02530139
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01EE04 SELUMETINIB
Atc Name
l 01 ee 04
Aig Number
0163981001
Company Name
Alexion Pharma GmbH
Company Address
Neuhofstrasse 34, Baar, --, Switzerland, 6340
Company Detail Path
/organization/alexion-pharma-gmbh
Company Information
Pharmaceutical Company Name
Alexion Pharma GmbH
Country Name
Switzerland
Province Name
Zug
City Name
baar,zug,country_ch
Address
Neuhofstrasse 34
Active Ingredients
SELUMETINIB (SELUMETINIB SULFATE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3e5b76a04fa3926e
Type
Standard
Back to Health Canada Approvals